FDA picks Dexcom for TEMPO pilot, skipping premarket review

thenextweb.com/news/fda-tem... The FDA named Dexcom its first TEMPO participant, allowing digital health devices to reach Medicare patients before authorisation in exchange for real-world data.

1 reportother

Claim audit

No BS check run yet — press ⚖ to extract this story's claims and verify them against independent sources.

All coverage